Rankings
▼
Calendar
AMPH Q2 2016 Earnings — Amphastar Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
AMPH
Amphastar Pharmaceuticals, Inc.
$863M
Q2 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$68M
Gross Profit
$32M
46.6% margin
Operating Income
$10M
15.2% margin
Net Income
$7M
10.1% margin
EPS (Diluted)
$0.15
QoQ Revenue Growth
+14.6%
Cash Flow
Operating Cash Flow
$9M
Free Cash Flow
$4M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$409M
Total Liabilities
$101M
Stockholders' Equity
$307M
Cash & Equivalents
$67M
Revenue Segments
Recombinant Human Insulin
$4M
100%
Geographic Segments
U
$68M
100%
← FY 2016
All Quarters
Q3 2016 →
